On April 20, 2022, Jeryl L. Hilleman notified Talis Biomedical Corporation of her resignation from her position as a member of the Companys Board of Directors and as a member and chairperson of the Audit Committee of the Board (the "Audit Committee"), to be effective immediately prior to the Company's 2022 annual meeting of the stockholders to be held on June 10, 2022 (the "Annual Meeting"). Ms. Hilleman's departure is not a result of any disagreement with the Company on any matter relating to the Company's
operations, policies or practices. Upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "N&CG Committee"), the Board has appointed current director and member of the Audit Committee, Randal Scott, as chairperson of the Audit Committee and current director, Kimberly J. Popovits, to the Audit Committee and Ms. Popovits as chairperson of the N&CG Committee, which appointments shall be effective as of immediately prior to the Annual Meeting.